WAM
ZIVOW

Warberg Asset Management’s Zivo Bioscience, Inc. Warrants ZIVOW Stock Holding History

Warberg Asset Management’s Portfolio ZIVOW Stock Details ZIVOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,975
Closed -$45.2K – 282
2023
Q3 		$45.2K Sell
100,975
-6,488
-6% -$3.26K 0.01% 134
2023
Q2 		$64.5K Sell
107,463
-4,700
-4% -$2.89K 0.01% 126
2023
Q1 		$65.3K Buy
112,163
+25,655
+30% +$19.5K 0.01% 138
2022
Q4 		$41.1K Buy
86,508
+1,854
+2% +$1.29K 0.01% 155
2022
Q3 		$51K Buy
84,654
+69,034
+442% +$57.8K 0.01% 172
2022
Q2 		$9K Sell
15,620
-10,560
-40% -$7.11K ﹤0.01% 215
2022
Q1 		$17K Buy
26,180
+6,739
+35% +$5.31K ﹤0.01% 190
2021
Q4 		$18K Sell
19,441
-20,559
-51% -$19.1K ﹤0.01% 180
2021
Q3 		$40K Buy
40,000
+10,000
+33% +$11.4K 0.01% 164
2021
Q2 		$45K Buy
+30,000
New +$39.6K 0.01% 174

Warberg Asset Management's ZIVOW Position: Q4 2023 in Review

Warberg Asset Management sold out of Zivo Bioscience, Inc. Warrants (ZIVOW) in Q4 2023, closing a stake of 100,975 shares — an estimated $45.2K sold.

Warberg Asset Management first reported a position in ZIVOW in Q2 2021 and held it in 10 quarters. The position peaked at $65.3K in Q1 2023. 0 funds tracked by Wall St. Rank hold ZIVOW as of Q4 2023.

  • Warberg Asset Management reported no remaining Zivo Bioscience, Inc. Warrants position as of Q4 2023 after selling out during the quarter.
  • Warberg Asset Management sold 100,975 Zivo Bioscience, Inc. Warrants shares in Q4 2023, an estimated $45.2K.
  • Warberg Asset Management first reported a position in Zivo Bioscience, Inc. Warrants in Q2 2021 and held it in 10 quarters.
  • Warberg Asset Management's Zivo Bioscience, Inc. Warrants position peaked at $65.3K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Warrants as of Q4 2023.

Based on Warberg Asset Management's 13F filing for Q4 2023, filed 7 Feb 2024.